GlassScriptPhysician profile
Prakashchandra B Patel
NPI 1558384099
$4,975.30
in general payments reported to CMS, 2019-2025
32 companies · $1,277 in 2025
The $1,277 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,113 · 2020: $1,020 · 2021: $146 · 2022: $191 · 2023: $48.08 · 2024: $180 · 2025: $1,277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Veran Medical Technologies, INC. | $1,263.96 | 2019-2020 | |
| Pulmonx Corporation | $681.88 | 2020-2022 | |
| Glaxosmithkline, LLC. | $541.07 | 2019-2025 | Nucala, Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $444.34 | 2019-2025 | Airsupra, Breztri |
| Insmed, INC. | $210.54 | 2019-2023 | |
| Inspire Medical Systems, INC. | $208.96 | 2025 | Inspire |
| Stryker Corporation | $170.61 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Davol INC. | $149.41 | 2025 | Progel Applicator Spray Tips |
| Grifols USA, LLC | $122.56 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.54 | 2019-2025 | Ofev |
| Genzyme Corporation | $114.21 | 2024-2025 | |
| Covidien LP | $113.49 | 2020 | |
| Genentech USA, INC. | $108.16 | 2019 | |
| Mylan Specialty L.P. | $69.90 | 2019-2024 | Yupelri |
| Advanced Respiratory, INC | $68.98 | 2019-2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $68.86 | 2025 | Hemosphere |
| Merck Sharp & Dohme LLC | $63.13 | 2019 | |
| Electromed, INC. | $56.63 | 2025 | Smartvest |
| Erbe USA INC | $50.00 | 2025 | Cryo2 |
| Novartis Pharmaceuticals Corporation | $49.57 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $49.12 | 2024-2025 | Dupixent |
| Ethicon INC. | $36.18 | 2025 | Monarch Platform |
| Viatris Specialty LLC | $32.41 | 2025 | Yupelri |
| Philips North America LLC | $30.14 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $29.00 | 2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $20.67 | 2025 | Glassia |
| Nuwellis, INC. | $19.80 | 2020 | |
| Circassia INC. | $19.00 | 2019 | |
| Vapotherm INC | $18.67 | 2019 | |
| Sunovion Pharmaceuticals INC. | $18.23 | 2020 | |
| Baxter Healthcare | $17.40 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Verona Pharma, INC. | $13.88 | 2025 | Ohtuvayre |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prakashchandra Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.